FTC, Teva
FTC opens investigation into Teva, escalating patent fight with pharma industry
Democrats have accused drug companies of “junk patent listings,” arguing that the industry is blocking generic competition and inflating patients’ costs.
After months of warnings, FTC opens investigation into Teva over ‘improper’ patents
The FTC is formally investigating Teva Pharmaceuticals after it refused to remove certain patents for asthma and COPD inhalers from a key federal registry.
FTC starts probe into Teva about some products' patents, Washington Post reports
The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers, the Washington Post reported on Monday,
FTC Investigating Teva Over Contested Patents On Inhalers
The Federal Trade Commission has ordered Teva Pharmaceuticals to provide internal documents about its patents on asthma and COPD inhalers. The move is part of a larger dispute over minor tweaks made by pharmaceutical companies to products to fend off generics competition,
FTC starts probe into Teva about some products' patents, Washington Post reports
(Reuters) -The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers ...
Maintaining Buy on Teva Amid FTC Probe: Minimal Impact and Strategic Patent Defense
Analyst Jason Gerberry from Bank of America Securities maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) and
FTC probes Teva over drug patents
The FTC has launched a probe into Teva Pharmaceuticals over contested drug patents the company refuses to remove from a federal registry, The Washington Post reported July 1. Last week, the FTC ordered Teva to turn over internal communications and financial data related to nearly two dozen patents for its asthma and COPD inhalers listed in the FDA's Orange Book,
Pharmalittle: We’re reading about FTC probing Teva patents, a Moderna flu vaccine contract, and more
The FTC is investigating Teva Pharmaceuticals after it refused to remove about two dozen patents for asthma and COPD inhalers from a federal registry.
FiercePharma8d
US FTC ramps up patent crusade with investigation into Teva's inhaler IP: report
While certain other drugmakers have relented in the face of the U.S. | The FTC has launched an investigation into Teva over ...
JD Supra8d
FTC Opens Investigation for Orange Book Listing of Medical Device Patents After Teva v. Amneal in District of New Jersey
The U.S. District Court for the District of New Jersey’s recent decision in Teva v. Amneal 1 elaborates on the standard ... and method of use patents. 17 Amneal and the FTC contended the patents ...
MarketWatch9d
Teva’s stock falls after report FTC has opened probe of patents
President Biden delivers remarks about his administration’s work to lower the cost of breathing treatments for asthma and COPD patients. Teva Pharmaceuticals Industries Ltd.’s stock fell 2% ...
Benzinga.com9d
STAT+: After months of warnings, FTC opens investigation into Teva over 'improper' patents
The U.S. Federal Trade Commission is formally investigating Teva Pharmaceuticals after the company refused to remove approximately two dozen patents for asthma and COPD inhalers from a key federal ...